<SEC-DOCUMENT>0001104659-21-065942.txt : 20210513
<SEC-HEADER>0001104659-21-065942.hdr.sgml : 20210513
<ACCEPTANCE-DATETIME>20210513161131
ACCESSION NUMBER:		0001104659-21-065942
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20210513
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210513
DATE AS OF CHANGE:		20210513

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			APPLIED DNA SCIENCES INC
		CENTRAL INDEX KEY:			0000744452
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380]
		IRS NUMBER:				592262718
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36745
		FILM NUMBER:		21919738

	BUSINESS ADDRESS:	
		STREET 1:		50 HEALTH SCIENCES DRIVE
		CITY:			STONY BROOK
		STATE:			NY
		ZIP:			11790
		BUSINESS PHONE:		631-240-8800

	MAIL ADDRESS:	
		STREET 1:		50 HEALTH SCIENCES DRIVE
		CITY:			STONY BROOK
		STATE:			NY
		ZIP:			11790

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PROHEALTH MEDICAL TECHNOLOGIES INC
		DATE OF NAME CHANGE:	20010504

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DCC ACQUISITION CORP
		DATE OF NAME CHANGE:	19990211

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DATALINK CAPITAL CORP/TX/
		DATE OF NAME CHANGE:	19980306
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2116284d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="text-align: center; margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="text-align: center; font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>WASHINGTON, D.C. 20549</B></P>

<P STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>PURSUANT TO SECTION 13 OR 15(d) OF THE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Date of Report (Date of earliest event reported):
May 13, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Applied DNA Sciences, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Exact name of registrant as specified in its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; width: 33%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Delaware</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(State or other jurisdiction<BR>
    of incorporation)</P></TD>
    <TD STYLE="text-align: center; width: 34%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>001-36745</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Commission File Number)</P></TD>
    <TD STYLE="text-align: center; width: 33%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>59-2262718</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(IRS Employer</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Identification No.)</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>50 Health Sciences Drive</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Stony Brook, New York 11790</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Address of principal executive offices; zip code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Registrant&#8217;s telephone number, including
area code: <B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>631-240-8800</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>N/A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Former name or former address, if changed since
last report)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#168;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#168;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#168;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#168;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&sect;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&sect;240.12b-2 of this chapter). Emerging growth company&nbsp;<FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.&nbsp;<FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><FONT STYLE="color: #231F20">Securities
registered pursuant to Section 12(b) of the Act:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #222222">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid; width: 38%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20"><B>Title of each class</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 20%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20"><B>Trading
    Symbol(s)</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 38%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20"><B>Name of each exchange on which registered</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">Common Stock, $0.001 par value</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">APDN</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">The Nasdaq Capital Market</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 2.02&nbsp;Results of Operations and Financial Condition.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On May 13, 2021, Applied DNA Sciences, Inc. (&#8220;Applied DNA Sciences&#8221;
or the &#8220;Company&#8221;) issued a press release announcing its results of operations for the fiscal quarter ended March 31, 2021.
A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The information furnished pursuant to this Item 2.02, including Exhibit
99.1, shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange
Act&#8221;), or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any
filing of the Company under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference
in such filing.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 9.01.&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(<I>d) Exhibits</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; padding-right: 0.8pt"><A HREF="tm2116284d1_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></A></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><A HREF="tm2116284d1_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release of Applied DNA Sciences, Inc. dated May 13, 2021 regarding results of operations for the fiscal quarter ended March 31, 2021.</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 39.65pt">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: May 13, 2021</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">APPLIED DNA SCIENCES, INC.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 47%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ James A. Hayward</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">James A. Hayward</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>EXHIBIT INDEX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit No.</B></FONT></TD>
    <TD STYLE="width: 0.1in">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 3pt"><A HREF="tm2116284d1_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></A></TD>
    <TD STYLE="padding-top: 3pt">&nbsp;</TD>
    <TD STYLE="padding-top: 3pt; text-align: justify"><A HREF="tm2116284d1_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release issued by Applied DNA Sciences, Inc. dated May 13, 2021 regarding results of operations for the fiscal quarter ended March 31, 2021.</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tm2116284d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="image_001.jpg" ALT="" STYLE="width: 270px; height: 42px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="image_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Applied DNA Second Fiscal Quarter 2021 Financial
Results Feature 384% Year-Over-Year Growth in Revenues</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&ndash;Revenues of $2.7
Million Compare with $0.6 Million a Year-Ago and $1.6 Million in the First Quarter of Fiscal 2021 &ndash;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>STONY BROOK, N.Y. - May 13, 2021</B> - <U>Applied
DNA Sciences, Inc.</U> (NASDAQ: APDN) (the &ldquo;Company&rdquo;), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing,
today announced consolidated financial results for the three and six months ended March 31, 2021. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;We are pleased to deliver
a strong fiscal second quarter with year-over-year revenue growth of 384%, capping an impressive first half of the fiscal year distinguished
by demand for our COVID-19 diagnostics and surveillance testing offerings (cumulatively &ldquo;COVID-19 testing business&rdquo;),&rdquo;
said Dr. James A. Hayward, president and CEO, Applied DNA. &ldquo;Our strategic and operational execution across non-COVID-19 testing
initiatives was also notable: we launched our first-ever clinical trial for a therapeutic candidate in the form of a LinearDNA&trade;
COVID-19 vaccine candidate for the veterinary market; advanced our cGMP capabilities and compliance roadmap that is a precursor to securing
more lucrative CMO relationships and lays the foundation potentially to disrupt the market for the manufacturing of nucleic acid-based
therapies; established a recurring revenue stream from the dietary supplements industry via Nutrition21&rsquo;s use of our CertainT platform;
strengthened our capital position, and deepened the management team to support our growth goals.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Continued Dr. Hayward, &ldquo;Our COVID-19 testing
strategy is increasingly informed by the acceleration in vaccine distribution. While traditional positive/negative testing remains a
component of our go-to-market strategy, we believe that we are well-positioned despite increasing vaccination rates given our ability
to detect SARS-COV-2 mutations. The expansion of our COVID-19 product portfolio with our Selective Genomic Surveillance&trade; (SGS&trade;)
Panel and expanded intended use of our EUA for our Linea<SUP>TM</SUP> COVID-19 Assay Kit to include asymptomatic serial screening testing
reflects a differentiated capability that expands our addressable market to include populations that can serve as a nexus for vaccinated
and under-vaccinated populations coming together with increasing frequency, such as skilled nursing facilities, and supports the reopening
of schools and workplaces. With our newly expanded intended use, together with the receipt of a New York clinical laboratory permit and
CLIA certification for COVID-19 testing using EUA-authorized methods and devices by our Applied DNA Clinical Labs, LLC subsidiary, we
believe our COVID-19 testing business presents a compelling opportunity for continued top-line growth.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;During the second half
of the fiscal year, we will focus on positioning our COVID-19 testing business for the expected ongoing need for tests and services to
support clients&rsquo; reopening strategies. While today our SGS Panel is available on a research use only (RUO) basis, our logical next
step would be to seek an EUA to bring this critical tool out from the lab and to every Emergency Room and other healthcare providers
that serve as the first line of defense against coronavirus variants to potentially inform their use of monoclonal antibody and convalescent
plasma therapies. Concurrently and in line with our phased approach to cGMP that is further bolstered by preliminary positive neutralizing
antibody results in domestic felines in our LinearDNA COVID-19 vaccine candidate clinical trial, we intend to explore an expansion of
our LinearDNA-based therapeutic pipeline into classes of therapies that will best utilize the many benefits of our LinearDNA platform.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;While the speed and shape
of the global recovery and timing of its impact on our supply chain security business remain uncertain, over the past year, we have seen
brands and their supply chains put more emphasis on supply chain security and transparency to enhance their market position exiting the
pandemic. We continue to position our CertainT<SUP>&reg;</SUP> platform as an enabler of the trust that both brands and consumers seek
in a post-pandemic world, which, following the passage of the Uyghur Forced Labor Prevention Act, has further catalyzed our interest
in leveraging our deep expertise in cotton genotyping and new next-generation sequencing capability to support brands&rsquo; regulatory
requirements and ethical responsibilities.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Concluded Dr. Hayward, &ldquo;Our
strong balance sheet affords us substantial strategic and operational flexibility, as well as the ability to make both short- and longer-term
investments in our businesses. We believe these investments in R&amp;D and pre-commercial and commercial initiatives further enhance
our growth profile.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Fiscal Second Quarter 2021 Financial Highlights:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 13.7pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Revenues
                                            increased 384% for the second quarter of fiscal 2021 to $2.7 million, compared with $552
                                            thousand reported in the same period of the prior fiscal year and increased 65% from $1.6
                                            million for the first quarter of fiscal 2021. The increase in revenues year over year was
                                            due primarily to an increase in service revenues of approximately $1.4 million and an increase
                                            of $767 thousand in product revenues. The increase in service revenue was primarily from
                                            revenues derived from our safeCircle&trade; COVID-19 surveillance testing. The increase in
                                            product revenue was mainly attributable to an increase in sales of our Linea&trade; COVID-19
                                            Assay Kit. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 13.5pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
                                            operating expenses increased to $4.6 million for the second fiscal quarter of 2021, compared
                                            with $3.0 million in the prior fiscal year&rsquo;s second quarter. This increase is primarily
                                            attributable to an increase in payroll of $315 thousand for staffing of Applied DNA Clinical
                                            Labs, LLC (ADCL), as well as an increase of $277 thousand for supplies and equipment to operate
                                            the ADCL laboratory. The increase in operating&nbsp;expenses also related to an&nbsp;increase
                                            in stock-based compensation expense of $422 thousand relating to officer stock option grants
                                            that vested immediately.&nbsp;&nbsp;The increase is also the result of increases in research
                                            and development expenses of $171 thousand and depreciation and amortization of $133 thousand.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 13.5pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
                                            loss applicable to common stockholders for the quarter ended March 31, 2021 was $1.5 million,
                                            or $0.21 per share, compared with a net loss of $3.0 million, or $0.79 per share, for the
                                            quarter ended March 31, 2020.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 13.5pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Excluding
                                            non-cash expenses, Adjusted EBITDA was negative $1.5 million and negative $2.6 million for
                                            the quarters ended March 31, 2021 and 2020, respectively. See below for information regarding
                                            non-GAAP measures.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 13.5pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash
                                            and cash equivalents stood at $13.9 million on March 31, 2021, compared to $7.8 million as
                                            of September 30, 2020. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Six-Month Financial Highlights:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 13.7pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Revenues
                                            increased 262% for the first six months of fiscal 2021 to $4.3 million, compared with $1.2
                                            million reported in the same period of the prior fiscal year. The increase in revenues year
                                            over year was due primarily to an increase in service revenues of approximately $2.0 million
                                            and an increase of $1.1 million in product revenues. The increase in service revenue was
                                            primarily from revenues derived from our safeCircle COVID-19 surveillance testing. The increase
                                            in product revenue was mainly attributable to an increase in sales of our Linea Assay Kit.
                                            </FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 13.5pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
                                            operating expenses increased to $9.0 million for the first six months of fiscal 2021, compared
                                            with $6.1 million in the same period of the prior fiscal year. This increase is primarily
                                            attributable to an increase in payroll of $1 million.&nbsp; The increase in payroll relates
                                            to additional headcount to staff at ADCL, as well as an increase for officer bonuses.&nbsp;The
                                            increase in operating&nbsp;expenses also related to an&nbsp;increase in stock-based compensation
                                            expense of $725 thousand primarily relating to officer stock option grants that vested immediately.&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 13.5pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
                                            loss applicable to common stockholders for the six-months ended March 31, 2021 was $6.3 million,
                                            or $1.00 per share, compared with a net loss of $5.6 million, or $1.76 per share, for the
                                            first six months of fiscal 2020.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>




<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 13.5pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Excluding
                                            non-cash expenses, Adjusted EBITDA was negative $3.9 million for the first six months of
                                            fiscal 2021, compared to negative $5.0 million for the same period in the prior fiscal year.
                                            See below for information regarding non-GAAP measures.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Fiscal Second Quarter 2021 Conference Call Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company will hold a conference call and webcast to discuss its
fiscal second quarter-end 2021 results on Thursday, May 13, 2021 at 4:30 PM ET. To participate on the conference call, please follow
the instructions below. While every attempt will be made to answer investors&rsquo; questions on the Q&amp;A portion of the call, not
all questions may be answered.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>To Participate: </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Participant
                                            Toll Free:1-844-887-9402 </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Participant
                                            Toll: 1-412-317-6798</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Please
                                            ask to be joined to the Applied DNA Sciences call</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Live webcast: <U>https://services.choruscall.com/mediaframe/webcast.html?webcastid=YaMBr3pT</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Replay (available 1 hour following the conclusion of the live call
through May 21, 2021): </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Participant
                                            Toll Free: 1-877-344-7529</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Participant
                                            Toll: 1-412-317-0088</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Participant
                                            Passcode: 10154121</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Webcast
                                            replay: <U>https://services.choruscall.com/mediaframe/webcast.html?webcastid=YaMBr3pT</U></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">For those unable to attend the live call, a copy of management&rsquo;s
PowerPoint presentation will be available for review under the &lsquo;IR Calendar&rsquo; section of the company&rsquo;s Investor Relations
web site: <U>https://adnas.com/molecular-based-security/investor-relations-calendar/</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Information about Non-GAAP Financial Measures</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As used herein, &ldquo;GAAP&rdquo; refers to accounting principles
generally accepted in the United States of America. To supplement our condensed consolidated financial statements prepared and presented
in accordance with GAAP, this earnings release includes Adjusted EBITDA, which is a non-GAAP financial measure as defined in Rule 101
of Regulation G promulgated by the Securities and Exchange Commission. Generally, a non-GAAP financial measure is a numerical measure
of a company&rsquo;s historical or future performance, financial position, or cash flows that either excludes or includes amounts that
are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. The presentation
of this non-GAAP financial information is not intended to be considered in isolation or as a substitute for, or superior to, the financial
information presented in accordance with GAAP. We use this non-GAAP financial measure for internal financial and operational decision-making
purposes and as a means to evaluate period-to-period comparisons of the performance and results of operations of our core business. Our
management believes that these non-GAAP financial measures provide meaningful supplemental information regarding the performance of our
business by excluding non-cash expenses that may not be indicative of our recurring operating results. We believe this non-GAAP financial
measure is useful to investors as they allow for greater transparency with respect to key metrics used by management in its financial
and operational decision making.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;EBITDA&rdquo;- is defined as earnings (loss) before interest
expense, income tax expense and depreciation and amortization expense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;Adjusted EBITDA&rdquo;- is defined as EBITDA adjusted to exclude
(i) stock-based compensation and (ii) other non-cash expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Applied DNA Sciences </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Applied DNA is commercializing LinearDNA&trade;,
its proprietary, large-scale polymerase chain reaction (&ldquo;PCR&rdquo;)-based manufacturing platform that allows for the large-scale
production of specific DNA sequences.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The LinearDNA platform has utility in the nucleic
acid-based <I>in vitro</I> diagnostics and preclinical nucleic acid-based drug development and manufacturing market. The platform is
used to manufacture DNA for customers as components of <I>in vitro </I>diagnostic tests and for preclinical nucleic acid-based drug development
in the fields of adoptive cell therapies (CAR T and TCR therapies), DNA vaccines (anti-viral and cancer), RNA therapies, clustered regularly
interspaced short palindromic repeats (CRISPR) based therapies, and gene therapies. Applied DNA has also established a COVID-19 diagnostic
and testing offering that is in the early stages of commercialization and is grounded in the Company&rsquo;s deep expertise in DNA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The LinearDNA platform also has non-biologic
applications, such as supply chain security, anti-counterfeiting and anti-theft technology. Key end-markets include textiles, pharmaceuticals
and nutraceuticals, and cannabis, among others.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Visit adnas.com for more information. Follow us on <U>Twitter </U>and <U>LinkedIn</U>.
Join our <U>mailing list</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company&rsquo;s common stock is listed on NASDAQ under ticker
symbol &lsquo;APDN,&rsquo; and its publicly traded warrants are listed on OTC under ticker symbol &lsquo;APPDW.&rsquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Applied DNA is a member of the Russell Microcap&reg; Index.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B><U>About the Linea&trade; COVID-19 Assay
Kit and the Linea&trade; COVID-19 Selective Genomic Surveillance&trade; (SGS) Mutation Panel</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Linea<SUP>TM</SUP> COVID-19 Assay Kit is
a real-time RT-PCR test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in respiratory specimens including anterior
nasal swabs, self-collected at a healthcare location or collected by a healthcare worker, and nasopharyngeal and oropharyngeal swabs,
mid-turbinate nasal swabs, nasopharyngeal washes/aspirates or nasal aspirates, and bronchoalveolar lavage (BAL) specimens collected by
a healthcare worker from individuals who are suspected of COVID-19 by their healthcare provider (HCP). The test is also intended for
use with anterior nasal swab specimens that are self-collected in the presence of an HCP from individuals without symptoms or other reasons
to suspect COVID-19 when tested at least weekly and with no more than 168 hours between serially collected specimens. The scope of the
Linea&trade; COVID-19 Assay Kit EUA, as amended, is expressly limited to use consistent with the Instructions for Use by authorized laboratories,
certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) to perform high complexity tests. The EUA will be effective
until the declaration that circumstances exist justifying the authorization of the emergency use of in vitro diagnostics for detection
and/or diagnosis of COVID-19 is terminated or until the EUA&rsquo;s prior termination or revocation. The diagnostic kit has not been
FDA cleared or approved, and the EUA&rsquo;s limited authorization is only for the detection of nucleic acid from SARS-CoV-2, not for
any other viruses or pathogens.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company is offering
surveillance testing in compliance with current CDC, FDA, and CMS guidances. The use of saliva and pooled sampling for surveillance testing,
which has been internally validated by the Company in compliance with current surveillance testing guidances, is not included in the
Company&rsquo;s EUA authorization for the Linea&trade; COVID-19 Assay Kit. The Linea&trade; COVID-19 Selective Genomic Surveillance&trade;
(SGS) Mutation Panel (the &ldquo;SGS Panel&rdquo;) is for Research Use Only (RUO) and shall not be used for clinical diagnostic purposes.
The SGS Panel has not been approved or authorized to diagnose, ameliorate and/or detect any disease by any U.S. or international regulatory
authority. In addition, all Next-Generation Sequencing services to be offered by the Company will be for Research Use Only (RUO) and
shall not be used for clinical diagnostic purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">The statements made by Applied
DNA in this press release may be &ldquo;forward-looking&rdquo; in nature within the meaning of Section 27A of the Securities Act of 1933,
Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. Forward-looking statements
describe Applied DNA&rsquo;s future plans, projections, strategies, and expectations, and are based on assumptions and involve a number
of risks and uncertainties, many of which are beyond the control of Applied DNA. Actual results could differ materially from those projected
due to its history of net losses, limited financial resources, limited market acceptance, the uncertainties inherent in research and
development, future clinical data and analysis, including whether any of Applied DNA&rsquo;s or its partner&rsquo;s diagnostic or therapeutic
candidates will advance further in the preclinical research or clinical trial process, including receiving clearance from the U.S. Food
and Drug Administration (U.S. FDA), the U.S. Department of Agriculture (USDA) or equivalent foreign regulatory agencies to conduct clinical
trials and whether and when, if at all, they will receive final approval from the U.S. FDA, the USDA or equivalent foreign regulatory
agencies, the unknown outcome of any applications or requests to U.S. FDA, USDA, equivalent foreign regulatory agencies and/or the New
York State Department of Health, the unknown limited duration of any Emergency Use Authorization (EUA) approval from U.S. FDA, changes
in guidances promulgated by the CDC, FDA and/or CMS relating to COVID-19 surveillance testing, disruptions in the supply of raw materials
and supplies, <FONT STYLE="font-family: Times New Roman, Times, Serif">the unknown ability to manufacture the vaccine candidates in large
quantities, the fact that the safety and efficacy of the vaccine candidates has not yet been established, the unknown ability of the
vaccine candidates to generate revenue or profit for Applied DNA, the fact that there has never been a commercial drug product utilizing
PCR-produced DNA technology approved for therapeutic use, and various other factors detailed from time to time in Applied DNA&rsquo;s
SEC reports and filings, including our Annual Report on Form 10-K filed on December 17, 2020, Quarterly Reports on Form 10-Q filed on
February 11, 2021 and May 13, 2021 and other reports we file with the SEC, which are available at <U>www.sec.gov</U>. Applied DNA undertakes
no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date hereof
or to reflect the occurrence of unanticipated events, unless otherwise required by law.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor contact: </B>Sanjay M. Hurry, 917-733-5573, sanjay.hurry@adnas.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Web:</B> www.adnas.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Twitter: </B>@APDN</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Financial Tables Follow</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><B>&nbsp;</B></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>APPLIED DNA SCIENCES, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CONSOLIDATED BALANCE SHEETS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31,</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">September 30,</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2021</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">ASSETS</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">(unaudited)</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Current assets:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 74%; font: 10pt Times New Roman, Times, Serif; text-align: left">Cash and cash equivalents</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">13,925,997</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">7,786,743</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Accounts receivable, net of allowance of $20,830 and $11,968 at March 31, 2021 and September 30, 2020, respectively</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,186,442</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">194,319</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Inventories</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">720,538</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">497,367</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Prepaid expenses and other current assets</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">586,207</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">599,296</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Total current assets</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">17,419,184</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">9,077,725</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Property and equipment, net</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,422,628</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,277,655</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Other assets:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Deposits</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">95,040</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">95,083</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Goodwill</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">285,386</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">285,386</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Intangible assets, net</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">559,346</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">605,330</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total Assets</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">20,781,584</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">11,341,179</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">LIABILITIES AND EQUITY</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Current liabilities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Accounts payable and accrued liabilities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,780,072</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,926,427</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Promissory notes payable-current portion</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">329,299</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Secured convertible notes payable , net of debt issuance costs</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,499,116</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Deferred revenue</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">350,057</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">511,036</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Total current liabilities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,130,129</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4,265,878</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Long term accrued liabilities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">31,467</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">848,307</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Promissory notes payable-long term portion</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">517,488</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total liabilities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,161,596</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">5,631,673</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Commitments and contingencies (Note H)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Applied DNA Sciences, Inc. Stockholders&rsquo; Equity:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of March 31, 2021 and September 30, 2020, respectively</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Series A Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- issued and outstanding as of March 31, 2021 and September 30, 2020, respectively</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Series B Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- issued and outstanding as of March 31, 2021 and September 30, 2020, respectively</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Common stock, par value $0.001 per share; 200,000,000 shares authorized as of March 31, 2021 and September 30, 2020, 7,486,120 and 5,142,779 shares issued and outstanding as of March 31, 2021 and September 30, 2020, respectively</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">7,488</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">5,144</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Additional paid in capital</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">294,781,015</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">275,548,737</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Accumulated deficit</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(276,162,006</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(269,835,650</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Applied DNA Sciences, Inc. stockholders&rsquo; equity:</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">18,626,497</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">5,718,231</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Noncontrolling interest</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(6,509</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(8,725</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total equity</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">18,619,988</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">5,709,506</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total liabilities and equity</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">20,781,584</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">11,341,179</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>APPLIED DNA SCIENCES, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSOLIDATED STATEMENTS OF OPERATIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">Three Month Period Ended</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">Six Month Period Ended</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">March 31,</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">March 31,</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2021</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2021</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Revenues</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; width: 48%; font: 10pt Times New Roman, Times, Serif; text-align: left">Product revenues</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">965,110</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">197,801</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">1,515,207</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">435,671</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Service revenues</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,706,432</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">354,672</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,772,476</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">750,321</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Total revenues</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,671,542</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">552,473</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4,287,683</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,185,992</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Cost of revenues</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">356,610</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">179,582</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">599,172</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">411,613</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Operating expenses:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Selling, general and administrative</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3,557,487</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,285,544</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">7,058,391</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4,658,957</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Research and development</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">874,055</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">703,018</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,622,420</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,267,444</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Depreciation and amortization</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">199,381</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">66,537</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">296,793</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">141,604</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total operating expenses</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">4,630,923</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,055,099</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">8,977,604</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">6,068,005</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">LOSS FROM OPERATIONS</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(2,315,991</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(2,682,208</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(5,289,093</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(5,293,626</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Interest income (expense), net</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">13,841</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(29,096</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">8,403</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(58,187</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Loss on extinguishment of convertible notes payable</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,774,662</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Gain on extinguishment of notes payable (PPP)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">839,945</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">839,945</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Income tax (expense)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Other expense, net</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(54,873</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(239,601</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(108,733</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(261,833</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">NET LOSS</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,517,078</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,950,905</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(6,324,140</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(5,613,646</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Less: Net (loss) income attributable to noncontrolling interest</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">278</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,220</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,216</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,190</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">NET LOSS attributable to Applied DNA Sciences, Inc.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,516,800</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(2,952,125</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(6,326,356</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(5,614,836</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Deemed dividend related to warrant modification</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,842</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net loss applicable to common stockholders</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,516,800</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,952,125</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(6,326,356</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(5,617,678</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net loss per share-basic and diluted</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.21</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.79</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(1.00</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(1.76</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Weighted average shares outstanding- basic and diluted</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">7,235,031</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">3,758,512</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">6,341,590</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">3,196,616</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>APPLIED DNA SCIENCES, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CALCULATION AND RECONCILIATION OF ADJUSTED
EBITDA</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">Three Month Period Ended March 31,</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">Six-Month Period Ended March 31,</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2021</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2021</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 48%; font: 10pt Times New Roman, Times, Serif; text-align: left">Net Loss</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,517,078</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,950,905</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">(6,324,140</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">(5,613,646</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Interest expense (income), net</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(13,841</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">29,096</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(8,403</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">58,187</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Depreciation and amortization</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">199,381</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">66,537</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">296,793</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">141,604</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(Gain) Loss on extinguishment of debt</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(839,945</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">934,717</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Provision for bad debt</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">19,637</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">19,637</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Stock based compensation expense</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">649,248</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">227,267</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,220,746</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">432,756</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total non-cash items</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">14,480</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">322,900</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,463,490</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">632,547</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Consolidated Adjusted EBITDA (loss)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,502,598</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,628,005</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(3,860,650</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(4,981,099</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  </TABLE>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 8; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ *@$. P$1  (1 0,1 ?_$ +L   $#! ,!
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M#PB[.WK-@E\[UVU9HB8J8*NW"39(3G'HI 46.0GN-^ =]CPBN0$# !BB!BF
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MG;=9G==[80W#OEM$)D!)X 4E'V:)Z!]F,;G*)?\ [W-G2=@/YB:T2(& 1*8
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,O"(X1'"(X1'"+__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ R #(  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  [ U(# 2(  A$! Q$!_\0
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MC1O'H?T_QIW\I?\ @,O\B>:/\T?O7^8^BF;QZ']/\:-X]#^G^-%_*7_@,O\
M(.:/\T?_  )?YCZ*C:10,Y'T8[1^>"*C\\=C'_WWG^@I.<%I*<8OM.48O[I-
M/\+>8TXO:4?_  )?YEBBH/.] I^CC_"CSO\ 9'_?:_X5'MZ'_/ZC_P"#8?\
MR1?*WM9^C7^9/153[0HZLG_?;4?:%_O)_P!]M5\]/_G[2_\ !D/_ )(SO/\
MY]U?_!4RW2'GLWY@?R:JOVA?[R?]]M2?:%[,A^DA_J157C_/#_P)!>:_Y=U?
M_!50MY/H?T_QHR?0_I_C53[2OJO_ '\/^-/\WZ?]]/\ X47C_/#_ ,"0N9_R
M5?\ P54+-%5_-'I_X^__ ,32^8/0?]_#_A4\\/YX?^!Q_P Q<W]VI_X+J?Y$
M]'X$?7']":K&< \E >V6/(]@/_UT&X'JG/'4C^E-.^L5*2>THIN+]);/Y&B4
MFDU&=GWA)/\ $LTUW"*SG)"C)"@D_@!R34'V@>J?F?\ "FM.I4[MA PV"6/*
MD,.@]0,=L]>*=I?R3_\  )?Y#Y9?RR_\!95O];TG2K:2]U34+/3+.+87N]1N
M;>QM@KF)=_GW4L,0C1IHED<L%5F"$[R!5Z"XCN4\R(DID@,5(5AV="?EDC==
MLD4J%HY(V5T<JV:_.K]J71O@WXA_:?\ V3=$^-=OX)U;PI=>#/VBGLM$^(T^
MGOX0U;7K71_ 0MH[W1M>GA\.:U>16%UJS6]GJL,R+%+/)'Y<D:R#I/V#9-)M
M?#OQWT?X>7D^H_ '0?V@/%NE_ &<7=U?:%;^#ET7PY<^)]+\#ZC=!VOO .D?
M$JX\967A66TN;S28+-)+#0[HZ/9V,45<D[7Y)V_F<6ENTM6[6;32=M6GHK78
MXS2NX5+/9\DK/T>SV:T;UT/NRZU"SL4EFO+B&T@A6-Y9[F6.""-)',:L\TK*
MB*7PFYV"[BJY!:K!D"H9 "RA"XV8=F !8!%7)<L!\H7)8D =:_/3XZ_"OP3\
M9/VQ?A'X3^)5C_PE'@F/]GOXNZAJ7@*_FE;PKXING\7?#ZTM&\5:/%''!X@M
M]'07%WI=KJ,TL5I?3-<V\8D+&OO?2K'3]$TS3=&TVU@L-)TC3[33-/LX-R6M
MGI]A;1VEI;0JY8K;VUO#'%&&8[8T )/)I-2LO=DKZJ\7MWWVW^YZ::K7^6?_
M (+FONNO)Z[?<R6+5],FN6LHK^SDO8[5+Q[)+JW:\CLY-HCNI+7S?/2WDW*4
MF>,1L.=W(%6C=1!2QW@@*=I7:Q9PA1 "1EV:2-%3.6>1$&2V*_GK_9T\ 'Q#
MH/P;^)/Q&_:2^ WPV_:9T+X]:#<_%G6+WPE?Z%^TK-\98_BI<:=\4O@5J_B+
MQ-\16U;5?!?Q"M9-7^&GASPY>^$O^$.?X9:AI'B7P5X<TJ*#2->L/WF\4K9S
M^&_$%K=:Y=>%+.?0-;BF\06EY;:;=^';>33[I+OQ%;W]SL%E<Z()&U);_P U
MH[:2SAN?,8*P8Y9K>$^VL&M>^[T)<HQTF^1M749WA)I[-1DKM.SLTW?6ST=^
MEL]7TW4#="PO;:\-E=2V5T+:>&<V]Y"2LUK-Y3OY5S"ZLD\$NR:&1'CE1'4I
M27VL:=IMM<7FH7<%G:6P!FN;J:*WMX]Y18=\\TB0QB>1UB@:5T269DB1C(RJ
MWYB?L!IX/^'WB3Q;\#-/\(_!2^\5>!_A-\)-8O\ X^_ 6^\_P[\;O#]TVM:-
MH^M_$NV"W5QI'QANKW2+[6_$#:WKOB;5_$%CK-IK$6L2Z;);1)ZE^VUX&TSQ
MWHWPPCNM?^#,E[X6\<:CKFG_  F_:(ODL?A'\8WD\(:SI%UX7U=9R"^OZ587
M,^N^%[VUL/$-KH6KF+6]3T">+[/+&6E_)/:_P.]M>E]]'IOIMJKGM*?\\/\
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MP_D>5? /XH/\:?A#\-?BT= _X19?'_A>P\2C0/[276CI*W_F@V)U%;/3!<@
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MT6U\8Q2'[+?V>CAI--U>TEC%YK5Q8WMSX6O]1>Q-O>@'].U-;./E(SD $J6
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M/&7C'7-,\,^%/"^E7NN^(_$.LW4=EI>C:+I<#W>H:C?74I6.&"VMXI'9B<\
M*'8A&_B._;0_X+=?M@?\%#?B[)^R-_P2Z\,>,/"W@C7[B32[?QSX<B2T^,OQ
M+TCSOLEYXFCU;4)8]'^#7PU:(RDZEJ+66NWEI)%<W/B/0Y;NRTQ?WF_X+E^!
M?CK\5O\ @E)\8="\"Z)=WOC>/1/A_P"*OBCX-\+R7=S/J7A/0]2L=:^(VC:4
M]J1=:E867V.XNI[6!9;J^TC3)Q;+]IE@8?Q[?\$X?'W_  3RNO!5G\,_C/\
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M'\0XZ<9'&<]QD9Z'OB(HQ;<%((.[YB"<^B_>1<Y^\#D#L3Q7UV0<64\JR_\
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ML,2$P&.\_-SN."VXDD[@<F,IN&=P)7@E#&_/#$9XVR;I.2,\N%4#!.2"3M
MRP /K/Q)S>IF&#S3$X/"8C'8?%^(N.Q=:4\13CB\5XC8.> QDZ5*'-2RZGE=
M"?+AJ6"C)8U0I_7ZD7'F?CS\-LN^KX["4<RQ^'PV+P' N6TJ-*&%4,/A>!,3
M0QF"IR7+_M?]H5Z4GCGB'2Y8U'##KEC&_P#.KXEOOVB_^"9O[7G[3WQ2\/\
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MOQ;IT>C>#VM]<BU/PWI^GWFHVQTVY06FH)):QO:7+*KB.50@_I\$3@-@*&+
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M *ZP\FIMM_6*BN[_ ,.F?/LZ.64B.0@*<GRWP,D8R=N!T-5)DD,9Q'*3E?\
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MB_[]15O_ *^-._U&EHT_]XK]/^W3)\#Q:?\ ME1736M+#/=>4O\ ,_+"2TO
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M1V]6'I^@KK7CUC%:_#5&T;6_V['[*W3V>^AF_!2+3_X7UK?_ )AL-U_[?O\
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M?[3/[.M#_P N=K@_],X_\<T?V;9CI9VGX1QUT+Z2N+M_R25#9?\ ,QS'LO\
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2CM?YRE+_ -*;M\K!1113*/_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
